Equity Insider News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for cancer patients is increasingly being shaped not by public institutions, but by ...

Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market's listing surge ...

As firms line up to enter Hong Kong's market for initial public offerings, estimates suggest the city may rank among the top three global venues this year Hong Kong's market for initial public ...

"Given the pace of AI innovation, we are confident that this is not a distant dream, but a reality that will unfold in the ...

SINGAPORE - Singapore biotech firm Mirxes launched its initial public offering (IPO) in Hong Kong on May 15, aiming to raise HK$1.09 billion (S$181 million) to support stronger growth in the ...

[SINGAPORE] Biotechnology company Nuevocor announced on Wednesday (May 7) that it completed a US$45 million Series B funding round from new and existing investors. This includes “significant ...

[SINGAPORE] Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as it seeks to raise HK$1.09 billion (S$181 million) to further grow the ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. PALO ALTO, Calif. — At an annual meeting usually focused on the industry ...

SINGAPORE, May 7, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), National ...

Novonesis, a world-leading biosolutions company, co-hosted its "Unlocking Value for a Sustainable Future" Partnering Day 2025 ...

“Singapore offers a uniquely supportive ecosystem for biotech startups, combining global connectivity, pro-innovation policies, strong IP protection, and ready access to quality suppliers and ...